Clinical Trial Update: Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) [Phase 1]

View source ↗

Summary

This report documents the completion of a Phase 1 safety and tolerability trial in patients with mild to moderate Alzheimer's disease. The study was sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED